A
Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
LSE:APH
Price:
33.1 GBX
-1.78%
Market Closed
Updated:
May 4, 2024
Alliance Pharma PLC
Operating Income
|
Alliance Pharma PLC
Operating Income Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Operating Income
£6.2m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Income
£8.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Income
$8.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
9%
|
|
|
Indivior PLC
LSE:INDV
|
Operating Income
$270m
|
CAGR 3-Years
45%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Income
$622m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Income
£24.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
See Also
What is Alliance Pharma PLC's Operating Income?
Operating Income
6.2m
GBP
6.2m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Operating Income amounts to 6.2m GBP.
What is Alliance Pharma PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-8%
-8%
Over the last year, the Operating Income growth was -69%. The average annual Operating Income growth rates for Alliance Pharma PLC have been -43% over the past three years , -25% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
